Related Experiment Videos
Recurrent pterygia--laser therapy: a preliminary report
1Free University of Berlin, Germany.
Indian Journal of Ophthalmology
|April 1, 1993
Summary
Argon laser therapy effectively treats recurrent pterygia (eye growths). Success rates were high for patients with one prior surgery, showing it
Area of Science:
- Ophthalmology
- Medical Technology
Background:
- Recurrent pterygia pose a significant challenge after initial surgical excision.
- Previous surgeries for pterygia can lead to increased recurrence rates and complications.
Purpose of the Study:
- To evaluate the efficacy and safety of Argon laser photocoagulation for treating recurrent pterygia.
- To assess the outcomes of Argon laser therapy based on the number of prior surgical excisions.
Main Methods:
- A cohort of 36 patients (42 eyes) with recurrent pterygia underwent Argon laser photocoagulation.
- Patients were monitored for a follow-up period of 9-12 months post-treatment.
Main Results:
- Argon laser therapy demonstrated a high success rate of 92.8% in cases of recurrent pterygia with one prior excision.
- A success rate of 64.2% was observed in patients with two or more previous excisions.
- The treatment was found to be safe with minimal complications.
Conclusions:
- Argon laser photocoagulation is a safe and effective therapeutic option for recurrent pterygia.
- Treatment outcomes are favorable, particularly in patients with fewer prior surgical interventions.
- Laser therapy offers a viable alternative for managing challenging recurrent pterygium cases.